Product Detail
Current Trends in Monoclonal Antibody Development and Manufacturing
Shire, Steven J.
Pricing & Availability
Available: 0
List Price:$299.00
Other formats:
E E Book + ProQuest Ebook Central
All Formats
Book Information
Edition:
1st
Publisher:
Springer Nature
ISBN:
0-387-76642-1 (0387766421)
ISBN-13:
978-0-387-76642-3 (9780387766423)
Binding:
Hardcover
Copyright:
2010
Publish Date:
01/10
Weight:
1.83 Lbs.
Pages:
351
Subject Class:
PRM (Pharmacology)
Remarks:
Print on Demand. Please allow additional time for delivery.
Return Policy:
Returns accepted up to 12 months provided no other recalls or return restrictions apply.
Table Of Contents:
View
Contributing Authors:
View
ProQuest Ebook Central:
Available in ProQuest Ebook Central™
View
Class Specifications
ISSN Series:
Biotechnology: Pharmaceutical Aspects
Discipline:
Micro/Immuno
Subject Definition:
Antibodies, Monoclonal
NLM Class:
QW 575.5
LC Class:
QP905
Abstract:
Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important class of molecules, monoclonal antibodies products will become increasingly prevalent over the next decade. Recently the regulatory review of monoclonal antibodies has been moved from Center for Biologics and Research to the Center for Drug Evaluation and Research (CDER) division of the US Food and Drug Administration. It is anticipated that CDER will expect a certain minimal amount of data to be provided as more of these products move through the regulatory pipeline. Current Trends in Monoclonal Antibody Development and Manufacturing will provide readers with an understanding of what is currently being done in the industry to develop, manufacture, and release monoclonal antibody products and what will be required for a successful regulatory submission.
close
Follow Matthews Book Co. on:
Copyright © 2001-2025 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews
Privacy Statement
Available in ProQuest Ebook Central™ View